文献速递血栓与止血

纤溶酶原激活物抑制剂1与胰腺癌静脉血栓形成

Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer.
PubMed 文献 · Blood Adv · 2021-01-01

胰腺癌患者静脉血栓栓塞(VTE)风险高。本研究分析血浆活性PAI-1与胰腺癌患者VTE的关联,并在小鼠模型中观察表达PAI-1的人胰腺肿瘤对静脉血栓溶解的影响。结果显示活性PAI-1水平与VTE风险独立相关,荷瘤小鼠血栓溶解受损,提示PAI-1参与胰腺癌相关VTE。

要点

  • 血浆活性PAI-1水平与胰腺癌患者VTE风险独立相关。
  • 荷PANC-1肿瘤小鼠活性人及小鼠PAI-1升高、纤溶酶活性降低。
  • 荷瘤小鼠下腔静脉结扎后第8天静脉血栓溶解受损。

核心结论

  • 结果提示PAI-1参与胰腺癌相关静脉血栓栓塞的发生。

研究设计与样本

  • 研究分析胰腺癌患者血浆活性PAI-1与VTE的关联,并在荷PANC-1肿瘤裸鼠中诱导下腔静脉血栓观察溶解。
  • 检测5种人胰腺癌细胞系PAI-1表达,PANC-1表达最高。
  • 活性PAI-1采用酶联免疫吸附试验测定。

主要发现

  • 荷PANC-1肿瘤小鼠活性人PAI-1和小鼠PAI-1均升高,纤溶酶活性降低。
  • 荷PANC-1肿瘤小鼠在下腔静脉淤滞第8天静脉血栓溶解受损,较非肿瘤对照差。

临床怎么用

  • 胰腺癌患者血浆活性PAI-1升高可能提示VTE风险增加,但尚不能作为常规预测指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pancreatic cancer patients have a high risk of venous thromboembolism (VTE). Plasminogen activator inhibitor 1 (PAI-1) inhibits plasminogen activators and increases the risk of thrombosis. PAI-1 is expressed by pancreatic tumors and human pancreatic cell lines. However, to date, there are no studies analyzing the association of active PAI-1 and VTE in pancreatic cancer patients. We investigated the association of active PAI-1 in plasma and VTE in pancreatic cancer patients. In addition, we determined if the presence of human pancreatic tumors expressing PAI-1 impairs venous thrombus resolution in mice. Plasma levels of active PAI-1 in patients with pancreatic cancer and mice bearing human tumors were determined by enzyme-linked immunosorbent assay. We measured PAI-1 expression in 5 different human pancreatic cancer cell lines and found that PANC-1 cells expressed the highest level. PANC-1 tumors were grown in nude mice. Venous thrombosis was induced by complete ligation of the inferior vena cava (IVC). Levels of active PAI-1 were independently associated with increased risk of VTE in patients with pancreatic cancer (subdistribution hazard ratio per doubling of levels: 1.39 [95% confidence interval, 1.09-1.78], P = .007). Mice bearing PANC-1 tumors had increased levels of both active human and active mouse PAI-1 and decreased levels of plasmin activity. Importantly, mice bearing PANC-1 tumors exhibited impaired venous thrombus resolution 8 days after IVC stasis compared with nontumor controls. Our results suggest that PAI-1 contributes to VTE in pancreatic cancer.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Hisada Y, Garratt KB, Maqsood A, et al. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer. Blood Adv. 2021. PMID: 33496742. doi:10.1182/bloodadvances.2020003149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。